Nordihydroguairaretic acid
Nordihydroguairaretic acid Brand names, Nordihydroguairaretic acid Analogs
Nordihydroguairaretic acid Brand Names Mixture
- No information avaliable
Nordihydroguairaretic acid Chemical_Formula
C22H30O3
Nordihydroguairaretic acid RX_link
http://www.rxlist.com/cgi/generic4/megace_es.htm
Nordihydroguairaretic acid fda sheet
Nordihydroguairaretic acid msds (material safety sheet)
Nordihydroguairaretic acid Synthesis Reference
No information avaliable
Nordihydroguairaretic acid Molecular Weight
342.472 g/mol
Nordihydroguairaretic acid Melting Point
218.0-220.0oC
Nordihydroguairaretic acid H2O Solubility
2 µg/mL (at 37°C for the acetate salt)
Nordihydroguairaretic acid State
Solid
Nordihydroguairaretic acid LogP
3.123
Nordihydroguairaretic acid Dosage Forms
Oral suspension containing 125 mg of megestrol acetate per mL; Tablet
Nordihydroguairaretic acid Indication
For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.
Nordihydroguairaretic acid Pharmacology
Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.
Nordihydroguairaretic acid Absorption
Variable, but well absorbed orally.
Nordihydroguairaretic acid side effects and Toxicity
No serious unexpected side effects have resulted from studies involving megestrol acetate oral suspension administered in dosages as high as 1200 mg/day.
Nordihydroguairaretic acid Patient Information
No information avaliable
Nordihydroguairaretic acid Organisms Affected
Humans and other mammals
